Philips and Mandaya Royal Hospital Puri sign seven-year partnership agreement to provide patient-centered care
October 15 2020 - 4:00AM
Philips and Mandaya Royal Hospital Puri sign seven-year partnership
agreement to provide patient-centered care
October 15, 2020
Turnkey solution for newly-built hospital combines latest
innovations in enterprise diagnostic imaging, connected care and
informatics, as well as service, maintenance and financing
Amsterdam, the Netherlands and Jakarta, Indonesia
– Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in
health technology, and Mandaya Royal Hospital Puri today announced
a seven-year strategic partnership agreement integrating a
comprehensive range of cutting-edge medical technologies and
solutions that will bring world-class healthcare services to
Mandaya Royal’s patients and staff. The agreement includes first of
kind imaging and image-guided therapy technologies for the region,
integrated informatics and connected monitoring solutions to
support leading clinical care delivery. Also included in the
partnership are Philips’ Ambient Experience solutions, which use
dynamic lighting, projection and sound to enhance the experience of
patients and staff. Support for the partnership has been provided
by the Netherlands’ Export Credit Agency, a first for Philips in
Indonesia.
Opening in early 2021, Mandaya Royal Hospital Puri will have
over 350 beds, six operating theatres, over 100 outpatient
examination rooms, three advanced medical centers – a
Cardiovascular Center, an Advanced Oncology Center, and a
Neuroscience Center – and 14 state-of-the-art specialist clinics,
and is expected to receive over a thousand patients each day.
Intended to be a national referral hospital for the entire
Indonesian archipelago, the hospital will strive to deliver
patient-centered care personalized to the needs of each patient,
incorporating advanced health technology to improve patient
outcomes. Philips will support Mandaya Royal Hospital Puri with its
end-to-end approach, providing integrated solutions across the
multi-year engagement to drive improvements in patient outcomes,
experience, quality of care and efficiency.
“We are firmly in line with the government’s intention to create
centers of excellence that can support integrated care pathways
across Indonesia,” said Dr. Benedictus R. Widaja, MBChB (UK),
President Director of Mandaya Hospital Group. “Mandaya Royal
Hospital Puri has been designed from the ground up as a
patient-centered facility. From the architecture to the layout and
even the lighting, all are designed to make the patient experience
positive and uplifting. Our philosophy aligns perfectly with
Philips’ concept of connecting patients and providers for more
effective, coordinated and personalized care. Building medical
services around the wellness of the patient is exactly what we plan
to offer at Mandaya Royal Hospital Puri.”
“As a leading health technology company, Philips provides
meaningful innovations in collaboration with healthcare providers
to deliver value-based healthcare,” said Pim Preesman, Managing
Director, Philips Indonesia. “We deliver solutions that take the
complexity out of healthcare through a truly integrated approach to
drive better health outcomes, improve the patient and staff
experience, and lower the cost of care. We are excited to partner
with Dr. Ben and his team to build an advanced, patient-focused
hospital based on smart technology and innovation.”
Mandaya Royal Hospital Puri will be equipped with the latest
advanced technology and solutions from Philips, including the
next-generation Azurion image-guided therapy system, the Ingenia
Ambition MR, the world’s first MR for helium-free operations and
the IQon Spectral CT, the world’s first and only detector-based
spectral CT. Enterprise informatics solutions including
IntelliBridge Enterprise and Vue PACS will support collaboration
and optimize workflows, shortening the path to precise diagnostic
decisions.
Connected patient monitoring and integrated analytics solutions
from Philips will also enable the continuous monitoring of patients
wherever they are in the system – providing a comprehensive
solution during the entire treatment and recovery process. The
IntelliSpace Critical Care and Anesthesia (ICCA) system is an
advanced clinical decision support and automatic documentation
solution, providing analytics, integrated care management, and
reporting throughout the ICU care cycle. Another system, the
IntelliVue Guardian Solution (IGS) is a patient monitoring and
workflow system that monitors and identifies subtle signs of
deterioration or warning signs in a patient's physiological
condition and then alerts staff to intervene in a timely
manner.
For further information, please contact:
Mark GrovesPhilips Global Press OfficeTel: +31 631 639 916
Email: mark.groves@philips.com Twitter: mark_groves
Yulin FebrinaCorporate Communication Manager, Philips
IndonesiaTel: +62 2965 1330E-mail: yulin.febrina@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health
technology company focused on improving people's health and
enabling better outcomes across the health continuum from healthy
living and prevention, to diagnosis, treatment and home care.
Philips leverages advanced technology and deep clinical and
consumer insights to deliver integrated solutions. Headquartered in
the Netherlands, the company is a leader in diagnostic imaging,
image-guided therapy, patient monitoring and health informatics, as
well as in consumer health and home care. Philips generated 2019
sales of EUR 19.5 billion and employs approximately 81,000
employees with sales and services in more than 100 countries. News
about Philips can be found at www.philips.com/newscenter.
- Mandaya Royal Hospital Puri, Indonesia
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Apr 2023 to Apr 2024